Steven A Smith

Title: Innovations of Steven A. Smith

Introduction

Steven A. Smith is a notable inventor based in San Jose, California. He has made significant contributions to the field of pharmaceuticals, particularly in cancer treatment. His innovative work focuses on the development of combinations of menin inhibitors and CYP3A4 inhibitors.

Latest Patents

Smith holds a patent for "Combinations of menin inhibitors and CYP3A4 inhibitors and methods of use thereof." This invention is directed towards combinations of menin inhibitors with one or more CYP3A4 inhibitors, pharmaceutical compositions thereof, and methods of treating cancer and other diseases mediated by the menin-HLL interaction. The patent outlines compounds that inhibit menin and are useful in treating diseases mediated by the menin-MLL interaction in combination with a strong CYP3A4 inhibitor. He has 1 patent to his name.

Career Highlights

Steven A. Smith is currently associated with Syndax Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work is pivotal in the ongoing fight against cancer, showcasing his commitment to improving patient outcomes through innovative therapies.

Collaborations

Some of his notable coworkers include Gerard M. Mcgeehan and Galit Rosen, who contribute to the collaborative efforts at Syndax Pharmaceuticals.

Conclusion

Steven A. Smith's contributions to the field of pharmaceuticals, particularly through his innovative patent, highlight his role as a key inventor in cancer treatment. His work continues to inspire advancements in medical research and therapy development.